Venadaparib

Venadaparib is a potent, selective, orally active PARP inhibitor. By inhibiting PARP, venadaparib prevents cancer cells from repairing SSBs and drives the conversion of SSBs into double-strand breaks. venadaparib triggers a phenomenon called synthetic lethality, which is cell death caused by perturbing two genes simultaneously without damaging normal cells. venadaparib is primarily designed to treat patients with homologous recombination deficiency (HRD).

• Supplier: Alfa Cytology
• Product #: BC0083